Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 7 studies | 22% ± 7% | |
microglial cell | 5 studies | 20% ± 3% | |
astrocyte | 5 studies | 24% ± 5% | |
glutamatergic neuron | 5 studies | 37% ± 15% | |
epithelial cell | 4 studies | 27% ± 9% | |
oligodendrocyte precursor cell | 4 studies | 22% ± 5% | |
interneuron | 4 studies | 31% ± 17% | |
oligodendrocyte | 4 studies | 20% ± 1% | |
ciliated cell | 3 studies | 24% ± 5% | |
GABAergic neuron | 3 studies | 39% ± 7% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 6 studies | 30% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 998.44 | 1445 / 1445 | 100% | 16.81 | 183 / 183 |
intestine | 100% | 1174.20 | 966 / 966 | 100% | 10.30 | 527 / 527 |
ovary | 100% | 1349.93 | 180 / 180 | 100% | 12.09 | 430 / 430 |
lung | 100% | 1212.13 | 578 / 578 | 100% | 10.93 | 1153 / 1155 |
breast | 100% | 1183.71 | 459 / 459 | 100% | 11.88 | 1115 / 1118 |
stomach | 100% | 801.85 | 359 / 359 | 100% | 12.35 | 285 / 286 |
prostate | 100% | 1126.56 | 245 / 245 | 99% | 9.35 | 499 / 502 |
brain | 99% | 897.79 | 2628 / 2642 | 100% | 12.18 | 704 / 705 |
bladder | 100% | 1106.43 | 21 / 21 | 99% | 9.22 | 500 / 504 |
thymus | 100% | 1255.50 | 653 / 653 | 99% | 7.77 | 599 / 605 |
uterus | 100% | 1423.05 | 170 / 170 | 99% | 9.08 | 454 / 459 |
pancreas | 100% | 588.01 | 328 / 328 | 99% | 7.50 | 176 / 178 |
skin | 100% | 1353.20 | 1809 / 1809 | 98% | 10.70 | 463 / 472 |
kidney | 100% | 865.51 | 89 / 89 | 98% | 7.77 | 879 / 901 |
adrenal gland | 100% | 783.45 | 258 / 258 | 91% | 4.75 | 209 / 230 |
liver | 100% | 566.87 | 226 / 226 | 87% | 4.36 | 352 / 406 |
adipose | 100% | 1099.23 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1019.86 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 7.54 | 29 / 29 |
spleen | 100% | 1113.58 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 8.55 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.55 | 1 / 1 |
muscle | 100% | 678.54 | 801 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 540.48 | 849 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 95% | 5.54 | 76 / 80 |
peripheral blood | 82% | 617.21 | 763 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0042981 | Biological process | regulation of apoptotic process |
GO_0007283 | Biological process | spermatogenesis |
GO_0030154 | Biological process | cell differentiation |
GO_0006508 | Biological process | proteolysis |
GO_0016579 | Biological process | protein deubiquitination |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
GO_0004843 | Molecular function | cysteine-type deubiquitinase activity |
Gene name | USP42 |
Protein name | Ubiquitin specific peptidase 42 Ubiquitin specific protease 42 ubiquitinyl hydrolase 1 (EC 3.4.19.12) Ubiquitin carboxyl-terminal hydrolase 42 (EC 3.4.19.12) (Deubiquitinating enzyme 42) (Ubiquitin thioesterase 42) (Ubiquitin-specific-processing protease 42) |
Synonyms | tcag7.880 |
Description | FUNCTION: Deubiquitinating enzyme which may play an important role during spermatogenesis. . |
Accessions | Q9H9J4 ENST00000404008.6 F8WD92 B4DP25 ENST00000465073.6 C9JPC9 ENST00000306177.10 [Q9H9J4-2] ENST00000426246.2 ENST00000521713.1 A4D2N7 A4D2N6 ENST00000451154.5 E7EWZ4 E5RJP3 |